Amneal Pharmaceuticals (NasdaqGS:AMRX) reported positive interim Phase 4 ELEVATE-PD data for CREXONT in Parkinson's, indicating meaningful clinical benefits for patients switching from existing ...
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the use of QVAR® (beclomethasone dipropionate ...
Launch of albuterol sulfate inhalation aerosol and beclomethasone dipropionate HFA inhalation aerosolBRIDGEWATER, N.J., April 14, 2026 (GLOBE ...
Beclomethasone dipropionate HFA inhalation aerosol is a corticosteroid indicated for the maintenance treatment of asthma as prophylactic therapy. “Our first metered-dose inhalation product is a ...
Beclomethasone dipropionate HFA 40mcg, 80mcg; per actuation; breath-actuated inhalation aerosol with a dose counter. Do not exceed recommended dose. Risk of local infections (eg, mouth/pharynx ...
BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has tentatively approved ...
The particle size distribution of QVAR was measured using the Andersen cascade impactor (series 20-800 Mark II, Ecomesure, Janvry, France) operating at 28.3 L/min. The endotracheal tube was connected ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results